Publications
Fuhrmann, M., Musyanovych, A., Thoelen, R., & Moebius, H. (2022). Determination of the dielectric constant of non-planar nanostructures and single nanoparticles by electrostatic force microscopy. Journal of Physics Communications, 6(12), 125005. https://doi.org/10.1088/2399-6528/aca87b
Sachs, I., Fuhrmann, M., Deferme,
2014-2010
Götze S, Coersmeyer M, Müller O, Sievers S: Histone acetylase inhibitors induce attenuation of Wnt signaling and TCF7L2 depletion in colorectal carcinoma cells. International Journal of Oncology 45(4), 1715-1723 (2014). https://www.spandidos-publications.com/10.3892/ijo.2014.2550
Balke D, Zieten I, Strahl A, Müller O, Müller S: Des
2009-2008
Götze S, Feldhaus V, Traska T, Wolter M, Reifenberger G, Tannapfel A, Kuhnen C, Martin D, Müller O, Sievers S: ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. BMC Cancer 9, 447 (2009). https://doi.org/10.1186/1471-2407-9-447
Marelli MM, Moretti RM, Mai S, Müller O, van Groen
2007-2006
Köster MP, Müller O, Pollerberg E: Adenomatous Polyposis Coli (APC) is differentially distributed in growth cones and modulates their local stability and steering. Journal of Neuroscience 27(46): 12590-12600 (2007). https://doi.org/10.1523/jneurosci.2250-07.2007
Fürstner A, Nevado C, Wasser M, Tremblay M, Chevrier C, Teply F, Aïssa
2004-2003
Karaguni IM, Gourzoulidou E, Carpintero M, Langerak A, Klein-Hitpaß L, Möröy T, Winde G, Waldmann H, Müller O: SMAF-1 inhibits the APC/b-catenin pathway and shows properties similar to these of the tumor suppressor protein APC. ChemBioChem 5(9): 1267-1270 (2004). https://doi.org/10.1002/cbic.200400078
Waldmann H, Karaguni IM, Carpi
2002
Tickenbrock L, Cramer J, Vetter I, Müller O: Structure of the aminoterminal nuclear export domain of the APC tumor suppressor protein. Annals of the New York Academy of Science 973: 109-111 (2002). http://dx.doi.org/10.1111/j.1749-6632.2002.tb04616.x
Brohm D, Philippe N, Metzger S, Bhargava A, Müller O, Lieb F, Waldmann H: Solid-Phase s
2001-2000
Andreyev HJ, Norman AR, Cunningham D, Oates J, Dix BR, Iacopetta BJ, Young J, Walsh T, Ward R, Hawkins N, Beranek M, Jandik P, Benamouzig R, Jullian E, Laurent-Puig P, Olschwang S, Müller O, et al.: Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. British Journal of Cancer 85(5): 692-696 (2001). https:
1999-1998
Deka J, Herter P, Sprenger-Haußels M, Koosch S, Franz D, Müller KM, Kuhnen C, Hoffmann I, Müller O: The APC protein binds to A/T rich DNA sequences. Oncogene 18: 5654-5661 (1999). https://doi.org/10.1038/sj.onc.1202944
Herter P, Kuhnen C, Müller KM, Wittinghofer A, Müller O: Intracellular distribution of beta-catenin in colorectal
1997-1990
Nimmrich I, Friedl W, Kruse R, Pietsch S, Hentsch S, Deuter R, Winde G, Müller O: Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP. Human Genetics 100: 345-349 (1997). https://doi.org/10.1007/s004390050514
Winde G,